Objectives: To evaluate how combining fractional laser-based resurfacing treatments with targeted cosmeceuticals leads to sustained improvement in skin quality, with emphasis on collagen remodeling, texture refinement, and pigment balance.
Introduction: Skin quality has become a central focus of aesthetic dermatology, encompassing tone, texture, firmness, hydration, and clarity. While laser resurfacing offers significant short-term improvements, maintaining and enhancing those results requires long-term skin support. This talk explores how integrating resurfacing procedures with ongoing cosmeceutical use can achieve lasting improvements in skin quality, particularly for aging and pigment-prone skin.
Materials / method: A review of clinical data and expert consensus was conducted, examining studies involving fractional CO₂, Er:YAG, non-ablative lasers, and microneedling RF. This was combined with long-term studies of topical antioxidants, peptides, growth factors, and barrier-repair agents used post-procedure. Studies were selected with a preference for Asian or Fitzpatrick III–V populations.
Results: Fractional laser resurfacing improves texture and dermal collagen for up to 6–12 months.
Adjunctive use of L-ascorbic acid, peptides, and lipids post-resurfacing enhances epidermal integrity and extends visible results.
Longitudinal data support the role of antioxidant and peptide-rich skincare in maintaining radiance, reducing PIH recurrence, and supporting collagen remodeling.
Conclusion: Procedural interventions provide the catalyst for skin quality improvement, but sustained results rely on ongoing skincare. A long-term, phased skincare protocol using clinically validated actives enhances outcomes and prevents regression, especially in pigment-prone skin types. Dermatologists should view resurfacing and cosmeceuticals as partners in long-term aesthetic care.
Divulgação de informações
Você recebeu algum patrocínio para sua pesquisa neste tema?
Não
Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não
Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não
Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não
Este trabalho não recebeu nenhum patrocínio direto ou indireto. O mesmo está sob a própria responsabilidade do seu autor.
